glp-1 drugs for inflammation calm beyond diabetes and weight loss GLP-1 medications aren't just about
Description
Gastroenterology 132:213157
C., Cariou, B., Pileti, M., Rose, L., Axelsen, M., Rowe, E., & DeVries, J
Retrieved from Lilly-b
Patient preferences for glucagon-like peptide 1 receptor-agonist treatment attributes
The discrepancy was reduced when restricting to the 195 participants with both survey and EHR data, but remained significant (self-report = 14.14% versus 8.43% in EHR, P = 1.1 10 9 paired t -test
